Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood and bone marrow, can affect people of all ages but is the most common type of leukemia in adults.
This article was originally published on MedicalXpress.com

